GRIFOLS reported EUR8.69B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Alcon AG USD 4.69B 41M Sep/2026
Almirall EUR 303.77M 21.04M Jun/2026
Amadeus IT EUR 2.53B 8.7M Sep/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Cie Automotive EUR 1.48B 58.65M Dec/2025
Demant DKK 13.13B 5.86B Jun/2026
Ence Energia y Celulosa EUR 549.8M 58.8M Sep/2026
Essilor EUR 9.66B 190M Jun/2026
Ferrovial EUR 10.04B 680M Jun/2026
Fresenius EUR 10.51B 952M Sep/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Inditex EUR 4.55B 110M Jun/2026
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Merck EUR 10.34B 866M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Philips EUR 6.98B 669M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
Smith & Nephew USD 3.21B 85M Jun/2026
UCB EUR 2.18B 634M Dec/2025
Viscofan EUR 68.06M 65K Sep/2026